Fenretinide in Treating Patients With Recurrent Malignant Glioma

NCT00006080 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: fenretinide

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]